3-D Matrix Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3410730000
JPY
352.00
15 (4.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.08 M

Shareholding (Apr 2026)

FII

0.03%

Held by 1 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a growth in Net Sales of 88.84%, the company declared Outstanding results in Apr 26

  • The company has declared positive results for the last 4 consecutive quarters
  • ROCE(HY) Highest at 92.22%
  • DEBT-EQUITY RATIO (HY) Lowest at -32.82 %
  • OPERATING PROFIT MARGIN(Q) Highest at 17.75 %
2

With ROE of 24.57%, it has a very attractive valuation with a 8.42 Price to Book Value

3

Majority shareholders : FIIs

 
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 43,766 Million (Small Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.29

stock-summary
Return on Equity

24.57%

stock-summary
Price to Book

8.45

Revenue and Profits:
Net Sales:
3,540 Million
(Quarterly Results - Apr 2026)
Net Profit:
1,802 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-31.12%
0%
-31.12%
6 Months
-30.43%
0%
-30.43%
1 Year
44.26%
0%
44.26%
2 Years
177.17%
0%
177.17%
3 Years
130.07%
0%
130.07%
4 Years
16.17%
0%
16.17%
5 Years
13.18%
0%
13.18%

3-D Matrix Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
60.32%
EBIT Growth (5y)
15.58%
EBIT to Interest (avg)
-152.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.61
Sales to Capital Employed (avg)
1.16
Tax Ratio
22.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
0.86%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
8.42
EV to EBIT
267.88
EV to EBITDA
267.88
EV to Capital Employed
11.52
EV to Sales
4.57
PEG Ratio
0.16
Dividend Yield
NA
ROCE (Latest)
4.30%
ROE (Latest)
24.57%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Apr 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Apr 2026 is 88.84% vs 16.85% in Apr 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Apr 2026 is 262.68% vs -349.19% in Apr 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'26",
        "Apr'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,540.10",
          "val2": "1,874.70",
          "chgp": "88.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "628.40",
          "val2": "-550.20",
          "chgp": "214.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.90",
          "val2": "14.80",
          "chgp": "-80.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "218.10",
          "val2": "6.50",
          "chgp": "3,255.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,801.50",
          "val2": "-1,107.40",
          "chgp": "262.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "177.50%",
          "val2": "-293.50%",
          "chgp": "47.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Apr'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Apr 2026 is 57.00% vs 51.11% in Apr 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Apr 2026 is 266.16% vs -878.94% in Apr 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'26",
        "Apr'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,886.30",
          "val2": "6,934.10",
          "chgp": "57.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,335.80",
          "val2": "-1,156.20",
          "chgp": "215.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.00",
          "val2": "74.40",
          "chgp": "-75.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "180.50",
          "val2": "4.60",
          "chgp": "3,823.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,155.90",
          "val2": "-2,501.20",
          "chgp": "266.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "122.70%",
          "val2": "-166.70%",
          "chgp": "28.94%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'26 - YoYstock-summary

Apr'26
Apr'25
Change(%)
Net Sales
3,540.10
1,874.70
88.84%
Operating Profit (PBDIT) excl Other Income
628.40
-550.20
214.21%
Interest
2.90
14.80
-80.41%
Exceptional Items
218.10
6.50
3,255.38%
Consolidate Net Profit
1,801.50
-1,107.40
262.68%
Operating Profit Margin (Excl OI)
177.50%
-293.50%
47.10%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Apr 2026 is 88.84% vs 16.85% in Apr 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Apr 2026 is 262.68% vs -349.19% in Apr 2025

Annual Results Snapshot (Consolidated) - Apr'26stock-summary

Apr'26
Apr'25
Change(%)
Net Sales
10,886.30
6,934.10
57.00%
Operating Profit (PBDIT) excl Other Income
1,335.80
-1,156.20
215.53%
Interest
18.00
74.40
-75.81%
Exceptional Items
180.50
4.60
3,823.91%
Consolidate Net Profit
4,155.90
-2,501.20
266.16%
Operating Profit Margin (Excl OI)
122.70%
-166.70%
28.94%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Apr 2026 is 57.00% vs 51.11% in Apr 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Apr 2026 is 266.16% vs -878.94% in Apr 2025

stock-summaryCompany CV
About 3-D Matrix Ltd. stock-summary
stock-summary
3-D Matrix Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available